FMO5 and Alzheimer disease: NADPH oxidase dependent production of O2·- has been identified as a major contributor to brain injury in cerebral ischemia [25-27], excitotoxicity [28], Alzheimer’s disease, Parkinson’s disease and other neurological diseases [29].